๐ข ๐๐๐๐ ๐๐: Eli Lilly Reports Strong Weight-Loss Data for Oral GLP-1 in Older Adults - $Eli Lilly(LLY.US) $Hims & Hers Health(HIMS.US) $Novo Nordisk AS(NVO.US)
๐ ๐๐๐ฒ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:โค Eli Lilly presented new ๐ ๐จ๐ฎ๐ง๐๐๐ฒ๐จ (orforglipron) data at ๐๐๐ ๐๐๐๐.โค Oral GLP-1 showed up to ๐๐.๐% weight loss in adults ๐๐+.โค Results came from Phase ๐ ๐๐๐๐๐๐-๐ and ๐๐๐๐๐๐-๐ trials.โค Benefits observed in patients both with and without ๐ญ๐ฒ๐ฉ๐ ๐ ๐๐ข๐๐๐๐ญ๐๐ฌ.โค Foundayo is the only approved ๐จ๐ซ๐๐ฅ ๐๐๐-๐ without food or water restrictions.โค Most common side effects were ๐ ๐๐ฌ๐ญ๐ซ๐จ๐ข๐ง๐ญ๐๐ฌ๐ญ๐ข๐ง๐๐ฅ symptoms like nausea and diarrhea.โค Safety profile remained generally ๐๐จ๐ง๐ฌ๐ข๐ฌ๐ญ๐๐ง๐ญ across age groups.The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments